CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (Unaudited) Statement - USD ($)	Total	Common Stock	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	AOCI Attributable to Parent [Member]
Beginning balance (shares) at Dec. 31, 2020		5,949,463
Beginning balance at Dec. 31, 2020	$ (15,540,812)	$ 5,949	$ 110,107,170	$ (123,665,970)	$ (1,987,961)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	408,295			408,295
Share-based compensation to employees	4,471		4,471
Shares issued in connection with vesting of restricted stock (shares)
Shares issued in connection with vesting of restricted stock	0		0
Accretion of Series A redeemable convertible preferred stock	(197,114)		(197,114)
Dividends on Series A redeemable convertible preferred stock	(277,170)		(277,170)
Foreign currency translation	86,398				86,398
Ending balance (shares) at Mar. 31, 2021		5,949,463
Ending balance at Mar. 31, 2021	(15,515,932)	$ 5,949	109,637,357	(123,257,675)	(1,901,563)
Beginning balance (shares) at Dec. 31, 2021		7,082,276
Beginning balance at Dec. 31, 2021	(12,965,983)	$ 7,082	112,349,613	(123,462,638)	(1,860,040)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(1,109,406)			(1,109,406)
Share-based compensation to employees	8,184		8,184
Accretion of Series A redeemable convertible preferred stock	(14,815)		(14,815)
Dividends on Series A redeemable convertible preferred stock	(300,921)		(300,921)
Foreign currency translation	33,510				33,510
Ending balance (shares) at Mar. 31, 2022		7,082,276
Ending balance at Mar. 31, 2022	$ (14,349,431)	$ 7,082	$ 112,042,061	$ (124,572,044)	$ (1,826,530)